| Oct 21 |
Top small-cap stock picks from Morgan Stanley following the group's upgrade to neutral
|
| Oct 14 |
Opening Day: Another trio of biotech IPOs make Friday debut
|
| Oct 8 |
MBX Biosciences earns Buy rating at three investment firms
|
| Sep 27 |
Biotech IPOs return as sector recovers after funding overhang
|
| Sep 23 |
RA Capital Management's Strategic Acquisition of Bicara Therapeutics Shares
|
| Sep 18 |
FMR LLC Acquires New Stake in Bicara Therapeutics Inc
|
| Sep 17 |
Bicara Therapeutics closes $362m IPO in flurry of biotech listing activity
|
| Sep 16 |
Bicara Therapeutics Announces Closing of $362 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
|
| Sep 13 |
Biotech IPO Shares Climb in Debuts After Deals Upsized
|
| Sep 13 |
Bicara, MBX Bio lead gainers as biotech trio makes trading debut
|
